HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshinori Iwatani Selected Research

Hashimoto Disease (Thyroiditis, Hashimoto)

5/2020Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
8/2017Association of IL-10-Regulating MicroRNAs in Peripheral Blood Mononuclear Cells with the Pathogenesis of Autoimmune Thyroid Disease.
5/2017Intraindividual variation of microRNA expression levels in plasma and peripheral blood mononuclear cells and the associations of these levels with the pathogenesis of autoimmune thyroid diseases.
1/2017TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
4/2016Increases of microRNA let-7e in peripheral blood mononuclear cells in Hashimoto's disease.
2/2015The relationship between skewed X chromosome inactivation and the prognosis of Graves' and Hashimoto's diseases.
10/2013IL-10 -592A/C polymorphism is associated with severity of Hashimoto's disease.
3/2012Functional polymorphisms in TBX21 and HLX are associated with development and prognosis of Graves' disease.
5/2009Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.
3/2008The -590CC genotype in the IL4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshinori Iwatani Research Topics

Disease

23Thyroid Diseases (Thyroid Disease)
11/2021 - 09/2002
16Hashimoto Disease (Thyroiditis, Hashimoto)
05/2020 - 09/2002
16Graves Disease (Basedow Disease)
05/2020 - 04/2003
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2009 - 08/2002
4Inflammation (Inflammations)
08/2017 - 10/2002
4Infections
01/2015 - 01/2003
4Activated Protein C Resistance (APC Resistance)
05/2009 - 08/2002
3Hypothyroidism
05/2009 - 09/2002
2Autoimmune Diseases (Autoimmune Disease)
08/2017 - 01/2016
2Carcinoma (Carcinomatosis)
04/2013 - 07/2009
2Goiter
02/2013 - 12/2007
2Neoplasms (Cancer)
08/2012 - 07/2009
2Hyperferritinemia
01/2009 - 10/2002
2Venous Thrombosis (Deep-Vein Thrombosis)
05/2006 - 11/2002
2Thrombosis (Thrombus)
03/2005 - 05/2004
2Venous Thromboembolism
03/2005 - 08/2002
1Thyroiditis
11/2021
1Bacteriuria
01/2019
1Familial Mediterranean Fever (Periodic Disease)
01/2019
1Vitiligo
01/2019
1Pathologic Processes
04/2016
1Cysts
10/2014
1Immunoglobulin G4-Related Disease
10/2013
1Non-alcoholic Fatty Liver Disease
06/2013
1Fatty Liver
06/2013
1Organophosphate Poisoning
02/2013
1Thyroid Nodule (Nodule, Thyroid)
01/2012
1Pre-Eclampsia (Preeclampsia)
07/2010
1Iron Overload
01/2009
1Stomach Neoplasms (Stomach Cancer)
11/2007

Drug/Important Bio-Agent (IBA)

9AntibodiesIBA
01/2017 - 08/2002
6Immunoglobulin G (IgG)IBA
10/2013 - 08/2002
6Phospholipids (Phosphatides)FDA LinkGeneric
05/2009 - 08/2002
5DNA (Deoxyribonucleic Acid)IBA
02/2015 - 01/2003
4Interleukin-10 (Interleukin 10)IBA
08/2017 - 03/2004
4Thyroxine (Levothyroxine)FDA LinkGeneric
02/2013 - 09/2002
4EnzymesIBA
01/2009 - 04/2003
4Prothrombin (Factor II)IBA
05/2006 - 08/2002
3Proteins (Proteins, Gene)FDA Link
02/2020 - 10/2002
3MicroRNAs (MicroRNA)IBA
08/2017 - 04/2016
3Messenger RNA (mRNA)IBA
04/2013 - 07/2009
3thyrotropin-binding inhibitory immunoglobulinIBA
02/2013 - 06/2004
3Interleukin-4 (Interleukin 4)IBA
05/2009 - 03/2004
3PhosphatidylserinesIBA
05/2006 - 05/2004
3Cardiolipins (Cardiolipin)IBA
05/2006 - 05/2004
3Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
03/2005 - 08/2002
3beta 2-Glycoprotein I (Apolipoprotein H)IBA
03/2005 - 08/2002
2AutoantibodiesIBA
01/2019 - 09/2002
2Iodide Peroxidase (Deiodinase)IBA
07/2018 - 10/2017
2InterleukinsIBA
08/2017 - 12/2007
2CytokinesIBA
10/2013 - 03/2004
2Protein SIBA
05/2009 - 11/2002
2Ferritins (Ferritin)IBA
01/2009 - 10/2002
2Antithyroid Agents (Antithyroid Drugs)IBA
12/2007 - 06/2004
2Immunoglobulins (Immunoglobulin)IBA
12/2007 - 04/2003
2Anti-Idiotypic AntibodiesIBA
05/2006 - 05/2004
2factor V LeidenIBA
11/2002 - 08/2002
1LigandsIBA
11/2021
1Retinoic Acid 4-Hydroxylase (CYP26B1)IBA
11/2021
1Vitamin A (Retinol)FDA LinkGeneric
11/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2020
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2020
1Interleukin-6 (Interleukin 6)IBA
11/2019
1rhododendrolIBA
01/2019
1Toll-Like Receptor 4IBA
01/2019
1ThyroglobulinFDA Link
09/2017
1Interleukin-12 (IL 12)IBA
07/2017
1Interleukin-18 (Interleukin 18)IBA
07/2017
1Toll-Like Receptors (Toll-Like Receptor)IBA
05/2017
1Biomarkers (Surrogate Marker)IBA
05/2017
1Type I Tumor Necrosis Factor ReceptorsIBA
10/2016
1Type II Tumor Necrosis Factor ReceptorsIBA
10/2016
1Histone Deacetylases (Histone Deacetylase)IBA
01/2016
1Interleukin-16 (Interleukin 16)IBA
01/2016
1ChemokinesIBA
01/2016
1Chemotactic FactorsIBA
01/2016
1Interleukin-8 (Interleukin 8)IBA
01/2016
1NAD (NADH)IBA
01/2016
1Sirtuin 1IBA
01/2016
1Chemokine CCL5IBA
01/2016
1Hepatitis B Core AntigensIBA
01/2015
1Natamycin (Pimaricin)FDA Link
10/2014
1propamidineIBA
10/2014
1Povidone-Iodine (Betadine)FDA LinkGeneric
10/2014
1Transaminases (Aminotransferases)IBA
06/2013
1Dietary IronIBA
06/2013
1Ezetimibe (Zetia)FDA Link
06/2013
1pralidoxime (Protopam Chloride)FDA Link
02/2013
1SaltsIBA
02/2013
1Biological ProductsIBA
08/2012
1CreatinineIBA
07/2010
1NestinIBA
07/2009
1Differentiation AntigensIBA
07/2009
1Long-Acting Thyroid Stimulator (LATS)IBA
05/2009
1Indicators and Reagents (Reagents)IBA
01/2009
1Transferrin (beta 2 Transferrin)IBA
01/2009
1Pharmaceutical PreparationsIBA
12/2007
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2007

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2015
1Organ Transplantation
01/2007